Development of an In Vitro Drug Release Method to Enable In Vitro-In Vivo Correlation of Potassium Chloride...

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Pharmacokinetics

Background:

• Predicting in vivo drug performance from in vitro tests is crucial for pharmaceutical development.
• Standard USP dissolution methods often fail to establish a level A in vitro-in vivo correlation (IVIVC).
• Potassium chloride extended-release (ER) matrix tablets require a reliable method for performance prediction.

Purpose of the Study:

• To develop and validate a discriminatory in vitro drug release method for potassium chloride ER tablets.
• To establish a level A IVIVC for predicting in vivo performance based on in vitro release data.
• To identify optimal in vitro test conditions that correlate with in vivo drug behavior.

Main Methods:

• Three potassium chloride ER formulations with varying release rates were tested.
• Urinary pharmacokinetic profiles were evaluated in healthy subjects.
• In vitro dissolution tests were modified by altering apparatus type, surfactant, and ionic strength.

Main Results:

• The standard USP method did not yield an IVIVC.
• A specific method using USP Apparatus I (50 rpm, 900 mL 150 mM NaCl, 40 mM SDS, 37 °C) successfully correlated in vitro release with in vivo data.
• A validated level A IVIVC model was established using urinary pharmacokinetic data.

Conclusions:

• Investigating and optimizing in vitro test conditions is essential for developing predictive dissolution methods.
• The developed method enables accurate prediction of potassium chloride ER tablet in vivo performance.
• This approach enhances the reliability of in vitro drug release testing for ER formulations.